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Abstract
Introduction: Arteriolargenesis can be induced by concomitant stimulation of nitric 
Oxide(NO)‐Angiopoietinreceptor(Tie)‐VascularEndothelialGrowthFactor(VEGF)
signaling in the rat mesentery angiogenesis assay. We hypothesized that the same 
combination of exogenously added growth factors would also have a positive impact 
on arteriolargenesis and, consequently, the recovery of blood flow in a model of uni‐
lateral hindlimb ischemia.
Results and Methods: NO‐Tiemicehadfasterbloodflowrecoverycomparedtocontrol
mice,asassessedbylaserspeckleimaging.Therewasnochangeincapillarydensity
withintheischemicmuscles,butarterioledensitywashigherinNO‐Tiemice.Giventhe
previouslydocumentedbeneficialeffectofVEGFsignaling,wetestedwhetherNO‐Tie‐
VEGFmicewouldshowfurther improvement.Surprisingly,thesemicerecoveredno
differently from control, arteriole density was similar and capillary density was lower. 
Dll4 is a driver of arterial specification, so we hypothesized that Notch1 expression 
wouldbeinvolvedinarteriolargenesis.TherewasasignificantupregulationofNotch1
transcriptsinNO‐Tie‐VEGFcomparedwithNO‐Tiemice.UsingsolubleDll4(sDll4),we
stimulatedNotchsignalingintheischemicmusclesofmice.NO‐Tie‐sDll4micehadsig‐
nificantly increased capillary and arteriole densities, but impaired blood flow recovery.
Conclusion: TheseresultssuggestthatDll4activationearlyoninrevascularization
can lead to unproductive angiogenesis and arteriolargenesis, despite increased vas‐
culardensities.Theseresultssuggestspatialandtemporalbalanceofgrowthfactors
needs to be perfected for ideal functional and anatomical revascularisation.
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1  | INTRODUC TION
PAD has become a global problem in the 21st century and is a com‐
mon morbidity factor associated with some chronic diseases, such as 
diabetes.1 Although amputation‐free survival has steadily increased 
in high income countries, retrospective long‐term follow‐up studies 
reveal that the severe metabolic damage caused by ischemia still leads 
to poor prognosis in critical limb ischemia patients.2TreatmentofPAD
relies upon effective vascular remodeling resulting in a “vascular tree,” 
comprising the coordinated induction of arteriole, venule, and capil‐
lary identities that are capable of controlling blood flow. Moreover, 
regulated perfusion requires the formation of muscularized conduit 
vessels to deliver sufficient blood flow to the capillary exchange 
vessels.
The early promise of preclinical trials usingVEGF as a ther‐
apeutic did not give rise to the expected results.3 Angiogenesis 
induced by VEGF over‐expression is abnormal as vessels lack
pericytes or VSMCs, appear thin walled and hypertrophic, and
are prone to regression upon VEGF withdrawal.4‐6 To develop
a mature, stable microvasculature, other proteins appear to be 
necessary.7
As simply over‐expressing individual growth factors has demon‐
strated that some, but not all aspects of therapeutic revascularization 
can be achieved, it seems likely that the spatial, temporal, and biochem‐
ical co‐ordination of specific growth factors will be key to effective 
vascular remodeling. As such, studies combining delivery of different 
growth factors have started to reportmore encouraging results. For
example, combiningVEGF165 and Ang1 improved the outcome in a 
diabetic rat model of myocardial infarction by reducing fibrosis and 
ventricular remodeling, along with increased angiogenesis.8 It has also 
been shown, in a rat dorsal skin flap model that the mechanism through 
which adenoviral‐mediated delivery of VEGF (through Ad.VEGF) in‐
creases tissue viability and blood flow is due to an increase in NO syn‐
thesis and release.9
Using a model of physiological angiogenesis, the rat mesentery 
assay, we previously described the process of arteriolargenesis, 
the generation of arterioles from capillaries.10‐12 We have shown 
that,byover‐expressingeNOS (endothelialnitricoxidesynthase),
we promote a NO‐mediated increase in blood flow, which gives 
rise toangiogenesisdependentuponVEGF‐VEGFRandAng1‐Tie
signaling,12 which was more beneficial than the combination of 
Ang1+VEGF alone.11 Furthermore, the combination of adenovi‐
ral‐mediateddeliveryofeNOSandAng1 (NO‐Tie) is sufficient to
promote arteriolargenesis,12 but to a reduced degree compared 
with adenovirally mediated delivery of eNOS, Ang1, and VEGF
(NO‐Tie‐VEGF).10
VEGF has been shown to induce activation of the Dll4 notch
pathway during neovascularization. Dll4 activation results in less 
permeable blood vessels, and a more mature vasculature, with more 
arterioles and fewer branch points. We therefore tested the hypoth‐
esisthataddinginDll4activationtotheNO‐Tie‐VEGFcombination
might generate an improved revascularization.
2  | MATERIAL S AND METHODS
2.1 | Viruses
Human embryonic kidney cells (HEK293) and CHO cells were pur‐
chasedfromATTCandusedtoexpandortestalladenovirusesused.
Ad.eGFP(enhancedgreenfluorescentprotein,usedascontrol)
and Ad.Ang1* (Angiopoietin 1) were a gift from Regeneron Inc., 
Tarrytown,USA.12Ad.eNOS(endothelialnitricoxidesynthase)was
a gift from Prof Keith Channon and gave rise to increased produc‐
tion of nitric oxide.12Ad.VEGFwaspreviouslycharacterizedasgiv‐
ingrisetotheover‐expressionofthehumanVEGF‐A165a isoform in 
the mesentery.6
Ad.sDll4 was custom designed and purchased from Vector 
Biolabs.ThesequenceofthesDll4wasasfollows:
MTPASRSACR WALLLLAVLW PQQRAAGSGI FQLRLQEFVN
QRGMLANGQSCEPGCRTFFR
ICLKHFQATF SEGPCTFGNV STPVLGTNSF VVRDKNSGSG
RNPLQLPFNFTWPGTFSLNI
QAWHTPGDDL RPETSPGNSL ISQIIIQGSL AVGKIWRTDE
QNDTLTRLSYSYRVICSDNY
YGESCSRLCK KRDDHFGHYE CQPDGSLSCL PGWTGKYCDQ
PICLSGCHEQNGYCSKPDEC
ICRPGWQGRL CNECIPHNGC RHGTCSIPWQ CACDEGWGGL
FCDQDLNYCTHHSPCKNGST
CSNSGPKGYT CTCLPGYTGE HCELGLSKCA SNPCRNGGSC
KDQENSYHCLCPPGYYGQHC
EHSTLTCADS PCFNGGSCRE RNQGSSYACE CPPNFTGSNC
EKKVDRCTSNPCANGGQCLN
RGPSRTCRCR PGFTGTHCEL HISDCARSPC AHGGTCHDLE
NGPVCTCPAGFSGRRCEVRI
THDACASGPC FNGATCYTGL SPNNFVCNCP YGFVGSRCEF
PVGLPPSFPW.
Ad.sDll4 gives rise to the over‐expression of the extracellular 
portion of Delta‐like ligand 4, which is sufficient to activate Notch 
signaling, nuclear translocation of NICD, and Hes/Hey upregulation 
in ECs.14
Viruses were titrated by end‐point dilution and purified using the 
AdEasy Virus Purification Kit (2 × 100).
2.2 | In vitro angiogenesis assay
CHO cells were infected at a MOI of 100 and used to produce ad‐
enovirus‐conditioned media for 3 days. Normal human dermal fi‐
broblast cells (NHDF,Promocell)wereseededontocoverslips for
3 days. Human dermal blood endothelial cells (HDBECs, Promocell) 
were then seeded on top of the fibroblasts and allowed to settle 
overnight. The addition of fibroblasts allowed for a continuously
renewing layer of fibronectin and collagen to be synthesized, which 
supported spontaneous organization of ECs into tubule‐like struc‐
tures.15Thecellculturemediawasthenreplacedwithhalfvolume
of fresh media and half volume adenovirus‐conditioned media and 
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changed every 2 days for 2 weeks, thus enabling us to test the func‐
tionality of the proteins produced via adenoviral‐mediated infec‐
tion. After 2 weeks, the media was removed, and the cells were 
fixed with ethanol, stained with polyclonal rabbit anti‐VE‐Cadherin 
(5 μg/mL, ab33168, Abcam), and counterstained with DAPI. z‐stack 
images of 5 sections containing tubes from each coverslip were ac‐
quired, and image analysis was undertaken blinded using ImageJ.16 
We counted number of endothelial tubes, measured tube segment 
length, and expressed sprout point and branch point number per 
unit area.
2.3 | Hindlimb ischemia, gene transfer, and color 
speckle imaging
In accordancewith theAnimal (Scientific Procedures) Act (UK) of
1986 prepared by the Institute of Laboratory Animal Resources, 
C57Bl6 mice were subjected to surgical induction of unilateral 
hindlimb ischemia, as previously described (Couffinhal et al., 1998). 
Anesthesia was induced with 5% isoflurane vaporized in 100% 
oxygen at a rate of 1 L/min and maintained at 2% isoflurane. Body 
temperature was controlled throughout with a homeothermic blan‐
ketandrectalprobe(HarvardApparatus).Theskinwasepilatedand
sterilized using a chlorhexidine‐based solution. All mice were admin‐
istered pre‐operative analgesic (buprenorphine at 0.05 mg/kg) and 
saline solution (0.9%NaCl at 40 mL/kg). An incision was cut in the 
groin region, and connective tissue was teased apart to expose the 
main artery supplying blood flow to the hindlimb.The nerve bun‐
dle was teased apart and the femoral artery was ligated in two sites 
above the epigastric branch and electrocoagulated in between, to 
induce ischemia to the left hindpaw. Immediately after ischemic in‐
duction, in all animals, 109 pfu of each adenovirus was injected in‐
tramuscularly in the ischemic adductor.The superficial blood flow
to both ischemic and non‐ischemic feet was measured using a color 
laserspeckleimagingsystem(MoorFLIP2;MoorInstruments)inan‐
esthetized animals with 1% isoflurane at days 0, 3, 7, 14, and 21 after 
induction of limb ischemia.17The ratio of blood flowbetween the
ischemic and contralateral foot was calculated to use as an index of 
percentage blood flow recovery.
2.4 | Digital droplet PCR
At day 3 post surgery, tissue was recovered from some animals and 
lysedusingTrizolwithmechanical homogenization to extractRNA.
1 μg RNA was extracted, treated with DNAse, and transcribed to cDNA 
usingPrimeScriptII(Takara).Per25μL reaction, 1 μL of transcript was 
added to 12.5 μLddPCRSupermixforprobes(Biorad),2.5μLTaqman
probe(LifeTechnologies),and9μL water. Droplets were generated by 
adding the 25 to 70 μLDropletoil(Biorad)usingaQX200dropletgen‐
erator(Biorad).AmplificationwascarriedoutusingstandardTaqman
protocolsusingaPCRthermalcycler(Biorad).Sampleswereanalyzed
using a QX100 droplet reader (Biorad). Thresholdingwasmanually
performed, based on negative and positive control results when auto‐
matic thresholding of values was not possible.
2.5 | Immunofluorescence
At the experimental end‐point, mice were euthanized and the is‐
chemic adductormuscleswere dissected and embedded inO.C.T.
compound in liquid nitrogen‐cooled isopentane. These muscles
were sectioned and stained with IB4 and α‐SMA‐Cy3.Sectionswere
imagedwith a confocalmicroscope (Leica SPE), and counts of 30
random microscopic fields per mouse were averaged. Blood vessel 
profiles measuring around 5 μm in diameter stained only with IB4 
were counted as capillaries, and those displaying a second cellular 
layerstainedwithSMA,surroundingtheinnerone,werecountedas
arterioles(forexamples,seeFigure1C).Resultswereexpressedas
density of capillaries and arterioles per mm2.
3  | RESULTS
The induction of unilateral hindlimb ischemia in 12‐week‐old male
C57Bl6 mice resulted in an immediate decrease in perfusion to <20% 
ofthepre‐surgeryratio(Figure1A).Bloodflowtendedtorecoverup
to 70% of the pre‐ischemia values in all animal groups by day 21 after 
surgery,reachingapeakbyday14afterischemia(Figure1B).Recovery
between groups was not different at the final time point, when tissues 
werecollected,stained(Figure1C)andimagesobtainedandanalyzed
forcapillary(Figure1D)andarterioledensity(Figure1E).
Intramuscular injection of adenovirus within the ischemic ad‐
ductor muscle of mice, inducing the over‐expression of growth fac‐
torsendothelialnitricoxidesynthase(Ad.eNOS)andAngiopoietin
1 (Ad.Ang1), led to a more rapid improvement in the increase of 
bloodflowintheischemichindpaw(Figure1A),butnodifference
in the total recovery. This difference in recovery profiles was
primarily attributable to a faster recovery of NO‐Tiemice (mice
injectedwithAd.eNOS+Ad.Ang1) compared to controlmice (Ad.
eGFP‐injectedmice) (Figure1B).Recoveryofbloodflowreached
64.5 ± 5.2% of baseline in NO‐Tiemice 14 days after ischemia,
dipping slightly after this. Surprisingly,whenmicewere injected
with Ad.eNOS+Ad.Ang1 + Ad.VEGF (NO‐Tie‐VEGF mice), there
was no significant initial improvement in blood flow, and the shape 
of the recovery profile was not different than that of control mice 
(Figure1B).
Analysis of muscle revascularization at 21 days after ischemia 
revealed that these early differences in blood flow, that were no 
longer present after day 7, were nonetheless accompanied by a 
marked change in the characteristics of the vascular network formed 
(Figure1C).CapillarydensitywasnotincreasedinNO‐Tiemicecom‐
paredtocontrolmice,anditsignificantlydecreasedinNO‐Tie‐VEGF
micewhencomparedwitheithercontrolorNO‐Tiemice(Figure1D).
Incontrast,arterioledensitywassignificantlyhigherinNO‐Tiemice
thancontrolmice,butnotalteredinNO‐Tie‐VEGFmice(Figure1E).
In order to assess whether the unbalanced arteriole and capillary 
density observed are caused by a failure in the pathways of arterial 
specificationduetoincreasedVEGFsignaling,weconductedagene
expressionanalysisusingddPCR(Figure2).
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Incontrolmice,transcriptsforendogenousVEGFandVEGFR2
were significantly upregulated 3 days after surgery in the ischemic 
leg, indicating an upregulation in this signaling pathway in response 
tohypoxia,asexpected(Figure2A).ThiswasnotthecaseinNO‐Tie
andNO‐Tie‐VEGFmice,wheretheslightincreaseintranscriptpro‐
portion of total RNA was not different from the contralateral leg, 
and significantly reducedwhen comparedwith controlmice. This
indicated that, even at this early time point, the severity of hypoxia 
andischemiainNO‐TieandNO‐Tie‐VEGFmicewasreducedrelative
to control.
Thus, if increasedVEGFsignalingdrivingangiogenesiswasnot
the cause of the imbalance observed in angiogenesis vs arterio‐
largenesis, maybe Notch signaling was causing this. While Dll4 was 
notsignificantlyupregulatedbyischemiaorinducedbyNO‐Tiesig‐
naling, its receptor Notch 1 was upregulated in the ischemic adductor 
ofNO‐Tie‐VEGFmicewhencomparedtoNO‐Tiemice(Figure2B).
Thispoints in thedirectionofapush towardvesselmaturation in
NO‐Tie‐VEGFmice,thatoccurredfartooearly,comparedtoNO‐Tie
mice, to have a positive impact in blood flow recovery.
We have previously shown that activation of Notch signaling by 
soluble Dll4 (sDll4) decreases vascular permeability, mainly due to 
an increased expression of VE‐Cadherin at intercellular junctions,14 
and thus we used an adenovirus (Ad.sDll4) to promote early vessel 
maturation in the hindlimb ischemia mouse model, in order to assess 
itseffectonrecoveryofbloodflow.Firstly,toconfirmthatsDll4was
able to induce angiogenesis as well, we used an in vitro angiogenesis 
assay, where co‐cultured fibroblasts and ECs were treated with ade‐
novirus‐conditionedmedia,stained,andimaged(Figure3).Intheun‐
stimulatedinvitroangiogenesisassay(eGFP),weobservedsingular
tubes that were not connected to one another, whereas the tubes in 
F I G U R E  1  VEGFinhibitsNO‐Tie‐
mediated revascularization in C57Bl6 
mice. (A) Laser speckle images from 
representative animals over the course 
ofrecovery.(B)Two‐wayrepeated
measures ANOVA of the ischemic/
contralateral ratio reveals that virus had 
a significant effect in the variation of 
recovery profiles (5.89% of total variance). 
Thiswasparticularlyimportantat3and
7daysaftersurgery,whenNO‐Tiemice
(injectedwithAd.eNOS+Ad.Ang1)had
faster blood flow recovery compared with 
controlmice(injectedwithAd.eGFP),
while there was no difference between 
controlandNO‐Tie‐VEGFmice(injected
withAd.eNOS+Ad.Ang1+Ad.VEGF).
n=12mice/group.Two‐wayrepeated
measures analysis of variance followed 
byTukey'smultiplecomparisontest:
*P < 0.05, **P < 0.01. (C) Confocal images 
from representative muscle sections of 
ischemic adductors stained with isolectin 
B4 for endothelial cells (green) and α‐
smooth muscle actin for vascular smooth 
musclecells(red).Scalebar=25μm. 
(D) Capillary density is reduced in NO‐
Tie‐VEGFmicewhencomparedtoboth
controlandNO‐Tiemice.(E)Arteriole
densityisincreasedinNO‐Tiemice
relative to control mice. n = 5‐6 mice/
group. Kruskal‐Wallis test with α = 0.05 
andDunn'smultiplecomparisontests:
*P < 0.05, **P < 0.01
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the treatment conditions (VEGF, sDLL4,orboth)weremore inter‐
connected(Figure3A).TreatmentwithVEGFresultedinthehighest
density of tubes (P<0.001vseGFP,Figure3B).TreatmentwithsDll4
alsoresultedinasignificantlyhigherdensityoftubesthaneGFPbut,
whenVEGFwasgivenincombinationwithsDll4,thedensityoftubes
was very similar to that of sDll4 alone. Conversely, mean tube seg‐
ment length for all experimental conditions decreased. When given 
alone,VEGFandsDll4ledtoadecreaseinmeantubesegmentlength
but, when given in combination, tube segment length was slightly 
longerandwasnotdifferentfromcontrol(Figure3C).Sproutdensity
wasincreasedaboveeGFPlevelswhentreatedwithVEGF,butsDll4
aloneresultedinthehighestsproutdensity(Figure3D).Whencells
weretreatedwithVEGF+sDll4,thisincreaseinsproutdensitywas
attenuated. Branch point density was also significantly increased 
aboveeGFPforallconditions(Figure3E).WeconcludedthatVEGF
was the most efficient in promoting angiogenesis and that, when 
sDll4wasgivenalone,or in combinationwithVEGF, it attenuated
this increase.
The role of Notch signaling in driving assembly of adherens
junctions and regulating endothelial barrier integrity has recently 
been described.14,18Thesearemolecularpathwaysinvolvedinves‐
sel maturation and, thus, precursors to arteriolargenesis. So, we
assessed theeffect of sDll4 inNO‐Tie‐induced recoveryof blood
flowafter ischemia (Figure4).Wefoundthatadenoviral‐mediated
sDll4 over‐expression in the ischemic adductor had no effect in re‐
covery of blood flow after ischemia when compared to control mice 
(Figure4A).However,sDll4significantlyimpairedthepositiveeffect
inbloodfluxofNO‐Tierecoveryafterischemia,specificallyatday14
aftersurgery (Figure4B).Surprisingly,additionofAd.sDll4further
worsened the outcomeofNO‐Tie‐VEGFmice aswell (Figure 4C).
Moreover, sDll4 addition significantly increased both capillary and 
arterioledensitiesinallanimalgroups(Figure4D‐I),whichpointsto
a mismatch between metabolic demands and blood vessel densities, 
leading to lack of blood flow control at the vascular network level.
4  | DISCUSSION
Similar to its effects on the ratmesentery assay,12 NO‐Tie had a
pro‐arteriolargenic effect in a unilateral murine model of hindlimb 
ischemia, without impacting on angiogenesis, giving rise to an accel‐
eratedrecoveryofbloodflow(Figure1).Eventhoughthisbeneficial
effect was not sustained at later time points, it happened even in the 
presenceof a significantly reducedendogenousVEGFsignaling in
theipsilateralleg,comparedtocontrolmice(Figure2A).
Intheratmesenteryassay,VSMCrecruitmentordifferentiation
is not inhibited by over‐expression of VEGF‐A.13 Indeed, NO‐Tie‐
VEGFmicewerestillabletoincreasearteriolargenesis;however,this
F I G U R E  2   IncreasesinVEGF‐A/KDRandNotch1signalingareconcomitantwithpoorbloodfluxrecovery.(A)VEGF‐AandKDR
transcripts were significantly upregulated in the ischemic leg compared to the contralateral leg of control animals (*P < 0.05, two‐tailed 
pairedt‐test)butthisdidnothappenintheotheranimalgroups.VEGF‐AandKDRtranscriptsweresignificantlylowerintheipsilateral
adductorsofNO‐TieandNO‐Tie‐VEGFanimalsthanontheischemicadductorsofcontrolanimals,althoughnodifferenceswereobserved
between them (***P<0.001,ANOVAwithHolm‐Sidakpost‐test).(B)AlthoughnodifferenceswereobservedinDll4expression,expression
ofitsreceptorNotch1wassignificantlyupregulatedinischemicadductorsofNO‐Tie‐VEGFmicewhencomparedtoNO‐Tiemice
(**P<0.005,ANOVAwithHolm‐Sidakpost‐test).(n=4animals/group)
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occurredattheexpenseofreducedcapillarydensity(Figure1C,D).
ItseemsthatasourceofexogenousVEGFmovesrevascularization
toward earlier vessel maturation, thereby disturbing the balance 
of the different vessel types needed for adequate control of blood 
flow.Itiswellestablishedthatover‐expressionofVEGFonitsown
does not have therapeutic utility for the treatment of peripheral 
ischemia,3buttheideathatVEGFsignalingisactuallydeleteriousto
revascularization capable of improving recovery of blood flow in this 
model of disease has only recently been proposed.19Severalstudies
haveproposedthatthesourceofVEGFisimportanttoitsfunction
inarteriogenesisandvesselmaturation.VEGFR2traffickingwithin
ECs through endocytic vesicles regulates arterial morphogenesis 20 
and requires the cytoplasmic domain of neuropilin 1.20 Moreover, 
ablation of the scaffold protein synectin expression in ECs, but not 
VSMCs,resultedinimpairedarteriogenesisinadultmice21 and this 
phenotype was rescued upon endothelial‐specific knockout of phos‐
photyrosine phosphatase 1b.22 Thus, it appears thatVEGF signal‐
ing andVEGFR2 internalization in specific endosomeswithin ECs
may be required for arteriolargenesis. However, when the source of 
VEGFcomesfromtheischemicmuscle,thesubsequentrecruitment
ofVSMCsmaypreventfurthersproutingangiogenesisandleadto
premature arterialization of the newly formed vasculature in the 
ischemic muscle.
Therefore,wesoughtsomemolecularcuestohelpusunderstand
this process and found that one of the genes involved in arterial 
specification,Notch1,wasupregulatedinNO‐Tie‐VEGFmice,when
compared toNO‐Tiemice (Figure2B). Jagged1/Notch1signaling
pathway has been implicated in endothelial‐mesenchymal transi‐
tion—it is activated in microvascular ECs in the bleomycin‐induced 
model of pulmonary fibrosis in rats, where it may induce α‐smooth 
muscle actin expression via a non‐canonical pathway involving 
NFκB.23 Activation of Notch 1 signaling has also been found in brain 
arteriovenous malformations in humans.24Furthermore,molecular
alterations in Dll4‐Hey2 signaling are associated with VSMC hy‐
pertrophy and hyperplasia in varicose veins.25 Recent gene expres‐
sion signatures associated with Notch ligands Dll4 and Jagged 1 in 
plaque material from PAD patients have been associated with dis‐
ease progression.26 Adult Dll4+/− mice have increased angiogenesis, 
F I G U R E  3   Ad.sDll4 increased sprouting but reduced branching. (A) HDBECs were co‐cultured on top of fibroblasts in an in vitro 
angiogenesisassay.TheyweretreatedwithconditionedmediaforeitherAd.eGFP,Ad.VEGF,Ad.sDll4,orAd.VEGF+Ad.sDll4everyother
day for 2 weeks (n = 3 experimental replicates, experiment was repeated three times). Cells were then fixed and stained for the endothelial 
junctionalmarker,VE‐Cadherin(green)andthenuclearmarker,DAPI(blue).(B)BothsDll4andVEGF+sDll4resultedinasignificantlyhigher
tube density (sDll4: P=0.0004,sDll4+VEGF: P=0.0005),thanthecontroleGFP,yetshortermeantubelengths(C).TreatmentwithsDll4
resulted in tubes with the most sprouts (16.33 ± 0.677 P=0.0091);however,VEGFaloneandincombinationwithsDll4alsoincreasedthis
(D).Additionally,allthreetreatmentsincreasedthedensityofbranches,withVEGFinducingthemostandsDll4aloneresultinginslightly
less than the combination treatment. One‐way ANOVA with a Bonferroni post‐test, with a 95% confidence interval. *P < 0.05, **P < 0.01, 
***P < 0.001, ****P < 0.0001
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decreased arteriolar density, more severe tissue ischemia, and poor 
bloodflowrecoveryafterfemoralarteryocclusion.Theyalsopres‐
ent increased plasma leakage, decreased flow‐induced outward re‐
modeling, increased arteriolar contractility, and impaired arteriolar 
responses to shear‐stress and vasoactive molecules.27
In the past, a different Ad.sDll4 has been used as a decoy, inhibit‐
ing Notch signaling, downregulating expression of Hes, and giving rise 
to a disorganized and non‐perfused capillary network in a model of 
hindlimb ischemia.28 However, we have found that sDll4 is sufficient 
to upregulate Hes expression and activate Notch signaling, tightening 
the endothelial barrier in vitro and in vivo.14 Here, we find that sDll4 
is sufficient to induce an angiogenic response. However, in an in vitro 
angiogenesis assay, the resulting tubule network has a different topol‐
ogy than theoneelicitedbyVEGF.TheEC tubes formedhadmore
blind‐endsandwerelessinterconnectedthanthoseformedbyVEGF
alone.WhenVEGFandsDll4weresimultaneouslyapplied,theaspect
of the network resembled that of sDll4‐only stimulation (Figure 3).
Given the rising interest and often conflicting data on the role of Dll4/
Notch signaling in promoting vessel maturation 27‐30 and our own ex‐
perience researching the role of Dll4 in regulating vascular permea‐
bility and intercellular communication,14 we also tested how Dll4/
Notch signaling affected recovery of blood flow after ischemia. We 
postulatedthatthedeleteriouseffectofVEGFcouldpossiblybeex‐
plained by the activation of Notch in the ischemic muscle, and that we 
F I G U R E  4  Ad.sDll4impairsrecoveryofbloodfluxinNO‐Tiemice,evenwhenparalleledbyincreasedangiogenesisandarteriolargenesis.
(A) Ad.sDll4 had no effect on recovery of blood flux after ischemia when compared to control mice but (B) a significant effect in the variation 
ofrecoveryprofileswasobservedwhenthiswasaddedtoNO‐Tiemice(3.22%oftotalvariance,***P = 0.0004). (C) Addition of Ad.sDll4 
furtherworsenedtheoutcomeofNO‐Tie‐VEGFmice(1.80%oftotalvariance,**P=0.0070).Two‐wayANOVAwithSidak'spost‐test:
*P<0.05,n=12mice/group.Inallanimalgroups,additionofAd.sDll4ledtoanincreaseinbothcapillary(D‐F)andarterioledensities(G‐I).
n=5‐6mice/group.Two‐tailedMann‐Whitneytestwith95%confidenceinterval:****P < 0.0001
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could be able to recapitulate this phenotype using sDll4. We observed 
a phenotype of unproductive angiogenesis and arteriolargenesis elic‐
itedbysDll4(Figure4D‐I).Thesignificantlydenservascularnetwork
hadnoeffectonrecoveryfromischemia(Figure4A)oradeleterious
effectontheNO‐Tie‐mediatedrecoveryofbloodflowafterischemia
(Figure 4B). sDll4 further worsened the outcome of NO‐Tie‐VEGF
mice(Figure4C).ThissuggeststhatsDll4mayhaveactedtoprevent
vessel maturation at earlier time points, leading to a denser, but less 
efficient vascular network with reduced functional capacity. It may be 
that forcing a pathway of arterial specification earlier on in the heal‐
ing process is deleterious, since it may bring about the uncoupling of 
excitation‐conduction in newly formed arterioles. It also points to the 
concept that, if the vascular network formed does not match the met‐
abolic demands of the tissue, then unproductive arteriolargenesis is as 
ineffective to recovery from ischemia as unproductive angiogenesis.
Theexperimentsdescribedhereuseamousemodelofischemic
revascularization that results in relatively rapid recovery. Given that 
the temporal administration of the adenovirus (AdV) here was all done 
immediately after the ischemia, it is quite possible that this model is 
neither representative of the human disease, where ischemia arises 
gradually, and that the AdV is given at the wrong time—it would be 
interesting to determine whether the time of AdV administration is 
critical for the positive effects of the different AdV combinations.
Together,theseresultssuggestthatthenegativeeffectofexog‐
enousVEGFinNO‐Tiemicerecoveryfrombloodflowmaybepar‐
alleled by, but is not synergistic with, Notch1 activation, and that 
the quality of the revascularization in terms of the balance between 
the temporal and spatial development of arterioles vs capillaries is 
critical for effective recovery from ischemia.
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